TETRALOGIC PHARMACEUTICALS CORP Interest Expense
TETRALOGIC PHARMACEUTICALS CORP reported Interest Expense of $1.76 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2016-11-03
- TETRALOGIC PHARMACEUTICALS CORP interest expense for the quarter ending 2016-09-30 was $1.76M, a 9.49% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP interest expense for the quarter ending 2016-06-30 was $1.72M, a 9.19% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP interest expense for the quarter ending 2016-03-31 was $1.68M, a 7.38% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP interest expense for the quarter ending 2015-12-31 was $1.64M, a 1.04% increase year-over-year.
- TETRALOGIC PHARMACEUTICALS CORP interest expense for fiscal 2015 was $6.38M, a 90.04% increase from fiscal 2014.
- TETRALOGIC PHARMACEUTICALS CORP interest expense for fiscal 2014 was $3.36M, a 21.39% increase from fiscal 2013.
- TETRALOGIC PHARMACEUTICALS CORP interest expense for fiscal 2013 was $2.77M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 126 month |
|---|---|---|---|---|---|
| 2016-09-30 | $1.76M 10-Q · filed 2016-11-03 | $3.48M derived: sum of 2 quarters · filed 2016-11-03 | $5.16M 10-Q · filed 2016-11-03 | $6.80M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-06-30 | $1.72M 10-Q · filed 2016-08-11 | $3.40M 10-Q · filed 2016-08-11 | $5.04M derived: sum of 3 quarters · filed 2016-08-11 | $6.64M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-03-31 | $1.68M 10-Q · filed 2016-05-04 | $3.32M derived: sum of 2 quarters · filed 2016-05-04 | $4.93M derived: sum of 3 quarters · filed 2016-11-03 | $6.50M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $3.25M derived: sum of 2 quarters · filed 2016-11-03 | $4.82M derived: sum of 3 quarters · filed 2016-11-03 | $6.38M 10-K · filed 2016-03-16 | |
| 2015-09-30 | $1.61M 10-Q · filed 2016-11-03 | $3.18M derived: sum of 2 quarters · filed 2016-11-03 | $4.74M 10-Q · filed 2016-11-03 | $6.37M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-06-30 | $1.57M 10-Q · filed 2016-08-11 | $3.14M 10-Q · filed 2016-08-11 | $4.76M derived: sum of 3 quarters · filed 2016-08-11 | $6.36M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | $1.56M 10-Q · filed 2016-05-04 | $3.19M derived: sum of 2 quarters · filed 2016-05-04 | $4.78M derived: sum of 3 quarters · filed 2016-05-04 | $4.92M derived: sum of 4 quarters · filed 2016-05-04 | |
| 2014-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $3.22M derived: sum of 2 quarters · filed 2016-03-16 | $3.36M derived: sum of 3 quarters · filed 2016-03-16 | $3.36M 10-K · filed 2016-03-16 | |
| 2014-09-30 | $1.60M 10-Q · filed 2015-11-04 | $1.73M derived: sum of 2 quarters · filed 2015-11-04 | $1.73M 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | $139.45K 10-Q · filed 2015-08-05 | $139.45K 10-Q · filed 2015-08-05 | |||
| 2014-03-31 | $3.42M 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $1.65M derived: sum of 2 quarters · filed 2015-02-26 | $2.56M derived: sum of 3 quarters · filed 2015-02-26 | $2.77M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $262.14K 10-Q · filed 2014-11-05 | $1.17M derived: sum of 2 quarters · filed 2014-11-05 | $1.38M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $905.95K 10-Q · filed 2014-08-05 | $1.11M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | $207.29K 10-Q · filed 2014-05-08 |